Connect with us

Health

7 Fascinating Facts About Magic Mushrooms

According to a Science & Justice Journal study, there are over 200 species of magic mushrooms. Furthermore, they grow all around the world.

Published

on

white fungi

While it’s fascinating in and of itself that a little mushroom can lead you down a mystical, mind-expansive journey, there’s still more than meets the eye to psilocybin cubensis and their psychedelic properties.

Individuals around the globe have long since recognized the therapeutic potential of Ontario’s magic mushroom. However, the United Nations’ Convention on Psychotropic Substances brought all clinical research on hallucinogens — including shrooms — to a halt globally in 1971.

Recently, researchers have revived the study of shrooms in a laboratory setting. While there’s still plenty to learn about psilocybin, what we know so far is sure to blow your mind.

Advertisement

There Are Over 200 Species of Psilocybe Mushrooms

According to a Science & Justice Journal study, there are over 200 species of magic mushrooms. Furthermore, they grow all around the world.

You can find psilocybe mushrooms naturally throughout North America, South America, Hawaii, Australia, Europe, and Asia. There’s a possibility you may have some growing in your backyard without realizing it!

Scientific Study of Shrooms Began in the 1950s

Shrooms have sustained a unique role in South American culture for centuries. Researchers have uncovered ceramics, metal objects, and textiles of psilocybe mushrooms in Peru that date back to 1200-200 BCE, says author Peter Trutmann.

Advertisement

However, the term “magic mushrooms” wasn’t coined by Robert Gordon Wasson until 1957, explains a Neuropsychopharmacology Journal review. The nickname first came about in his article, “Seeking the Magic Mushroom,” which was published in LIFE magazine.

One year later, Swiss chemist Albert Hoffman discovered the magic behind said mushrooms: psilocybin.

“Microdosing” Magic Mushrooms Has Taken Over the STEM Field

Among biohacking and other productivity trends that have taken hold of STEM professionals, microdosing mushrooms are among them.

Advertisement

“Microdosing” means you’re consuming a sub-perceptual dose of psilocybin. This allows you to experience the benefits of shrooms, such as boosting your mood, without the hallucinogenic effects typically associated with tripping.

In more ways than one, microdosing is to psilocybin as CBD is to THC.

According to an International Journal of Neuropsychopharmacology study, many STEM field professionals report microdosing shrooms for the following reasons:

Advertisement
  • Performance enhancement (36 percent)
  • Mood enhancement (29 percent)
  • Symptom relief (14 percent)
  • Curiosity (15 percent)
  • Enhancing empathy and spirituality (5 percent)

Microdosing shrooms have other benefits, as well. A Frontiers in Psychiatry study found microdosing effectively alleviated symptoms of depression, anxiety, ADHD, migraines, and chronic pain, among other conditions.

Magic Mushrooms Are Among the Most Effective Smoking Cessation Tools to Date

Tobacco is at the root of at least seven million deaths annually around the globe. Despite the detrimental consequences of smoking, experts say it’s still “just as hard (or harder)” to quit as cocaine or heroin.

From nicotine patches to cognitive behavioral therapy, current tools to help individuals stop smoking are lackluster. According to a study published by The American Journal of Drug and Alcohol Abuse, less than 31 percent of individuals remain smoke-free one-year after using these tools. 

That’s where magic mushrooms unexpectedly pop into the picture. Their study found 67 percent of participants were still smoke-free during 12-months after receiving two to three moderate to high psilocybin doses. At an even longer-term follow-up, 60 percent were still smoke-free.

Advertisement

Additionally, almost 87 percent of the participants rated their experiences with shrooms as one of the top five “most personally meaningful and spiritually significant” experiences of their lives.

Shrooms May Cause “Ego Death”

While microdoses of magic mushrooms boost your mood and productivity, higher doses may trigger a phenomenon known as “ego death.”

Ego death is a mystical-type experience in which one “loses their sense of self.” It’s comparable to an extreme state of disassociation, yet it’s regarded as a profoundly positive experience.

Advertisement

A Frontiers in Human Neuroscience study says ego distortions are “central to the psychedelic experience.” From a psychoanalytical perspective, ego death is viewed as a “disruption of ego boundaries.” This causes the lines between your sense of self and the world around you to become blurred.

The respondents in their study said “ego death” made them feel:

  • “At one with the universe”
  • “A sense of union with others”
  • “Less absorbed by my own issues and concerns”
  • “All notions of self and identity dissolved away”

While this is an overwhelming experience for some, set and setting play major roles in the outcome of your trip. If you’re in a safe, comforting environment, it’s likely you’ll embrace the process positively.

You Can Brew Magic Mushrooms Into Tea

For those who aren’t too fond of shrooms’ signature bitter taste, you can brew them into a magical tea. In addition to its mystical properties, the tea looks quite mythical thanks to its bright blue color.

Advertisement

It’s quite easy to brew magic mushroom tea, too. All you’ll need is boiling water, reusable tea-bags, and some dried shrooms.

After boiling your shrooms into tea, you can flavor it however you please. Some may opt for lemon while others will stick to good ole fashion honey. You may also brew your shrooms with another tea, such as black tea or herbal tea, for additional flavor.

Psilocybin Increases Serotonin

The active compound in shrooms, psilocybin, is a serotonin agonist. Serotonin is a very important hormone that regulates your mood, digestion, sleep, and blood clotting, says the Hormone Health Network.

Advertisement

Serotonin irregularity is also implicated in several conditions ranging from depression to migraines. This further supports the potential of psilocybin in a clinical setting.

In Conclusion

Magic mushrooms are a fascinating, powerful psychedelic with the potential to open your mind in enriching and therapeutic ways. Although shrooms are everywhere, they didn’t make their way into scientific study until the mid-20th century.

With the current revival of psychedelic research, there’s still plenty for researchers to learn about the mystical world of magic mushrooms. However, research thus far has placed great emphasis on their potential for healing psychological disorders.

Advertisement

Learn more about couples rehab centers and how they help partners who are struggling with addiction.

Disclaimer: Psilocybin is potentially an illegal substance, and we do not advise you to take psilocybin where it is unlawful to do so. The following information exists solely for educational purposes. Ann Arbor dispensary receives the first recreational marijuana license in Michigan. 

Advertisement

Rebecca Siggers is a passionate writer & guest blogger. Writing helps her to improve her knowledge, skills & understanding about the specific industry. She loves writing & sharing her knowledge mostly in the Travelling Industry. She believes traveling is the key to a peaceful life & wants to spread her belief across the world. Apart from writing, she loves Traveling and Reading.

Health

IIT-K and BFI collaborate to drive healthcare innovation in India

Published

on

By

IIT-K and BFI forge partnership to accelerate healthcare innovation in India

Kanpur, April 17 (IANS) – The Indian Institute of Technology Kanpur (IIT-K) has entered into a strategic partnership with Blockchain For Impact (BFI) to drive advancements in healthcare in India. Under the BFI-Biome Virtual Network Programme, this collaboration aims to nurture innovations in the healthcare sector.

As part of the partnership, BFI will support IIT Kanpur in promoting entrepreneurial initiatives through the Startup Incubation & Innovation Centre (SIIC). A Memorandum of Understanding (MoU) was signed at IIT Kanpur by Prof. Kantesh Balani, Dean of Resources and Alumni (DoRA), IIT Kanpur; and Dr. Gaurav Singh, CEO BFI.

BFI has committed to allocating over $150,000 across three years to develop programmes tailored to healthcare-focused startups at IIT Kanpur’s SIIC. This collaboration harnesses IIT Kanpur’s expertise in fostering entrepreneurship and BFI’s dedication to advancing biomedical research.

Prof. Kantesh Balani, DoRA, IIT Kanpur, expressed his optimism about the partnership, stating, “This MoU will help us share knowledge, support startups effectively, and improve our capacity-building efforts.” Dr. Gaurav Singh, CEO of BFI, highlighted the inspiring work of IIT Kanpur incubatees in healthcare innovation and the alignment of missions to accelerate impactful solutions in biomedical research.

This partnership signifies a significant step towards advancing healthcare innovation in India by leveraging expertise and resources. The collaboration between IITK and BFI holds promise for improving public health and ensuring equitable healthcare access for all.

Continue Reading

Health

Doctors are hopeful that gene therapy could be a breakthrough for haemophilia, a blood disorder

Published

on

By

Gene therapy holds promise for blood disorder haemophilia: Doctors

On World Haemophilia Day, doctors highlighted the potential of gene therapy in treating haemophilia, a hereditary blood disorder. Haemophilia is caused by missing or defective clotting factors and raises the risk of severe bleeding and joint damage. Genetic counselling and screening are crucial for affected individuals. India has a high number of haemophilia cases, but many go undiagnosed due to lack of screening capabilities.

Gene therapy offers a promising approach to treating haemophilia by delivering functional genes to correct the genetic defect responsible for deficient clotting factor production. Recent clinical trials show positive outcomes, including the use of lentiviral vectors at CMC Vellore. While current treatment involves factor VIII infusions, gene therapy may offer a cure for haemophilia, especially in low and middle-income countries.

According to Anoop P, Sr. Consultant – Haematology at Aster RV Hospital, “Gene therapy is a potentially curative treatment for haemophilia.” It allows for editing the faulty gene of a baby inside the uterus, known to be born with haemophilia due to a family history. Ongoing research on gene therapy shows promising results, indicating a potential paradigm shift in the management and cure of haemophilia.

Continue Reading

Health

The Connection Between Daytime Sleep and Increased Risk of Dementia

Published

on

By

How daytime sleep can raise dementia risk

New Delhi, April 17 (IANS) Compensating for lack of sleep during the daytime may not be as effective as previously thought, warned Dr. Sudhir Kumar, a neurologist based in Hyderabad. According to Dr. Sudhir, daytime sleep is not in sync with the body’s natural clock and can increase the risk of dementia and other psychiatric disorders.

Dr. Sudhir, from Indraprastha Apollo Hospitals, highlighted in a post on X.com that daytime sleep is lighter and does not fulfill the body’s sleep requirements. He explained, “This fact is supported by numerous studies of night shift workers, who are predisposed to stress, obesity, cognitive deficits, and an elevated risk of neurodegenerative diseases.”

The neurologist pointed out that the glymphatic system, responsible for clearing the brain of protein waste products, is most active during sleep. Therefore, when there is a lack of sleep, the glymphatic system may fail, increasing the risk of dementia. Dr. Sudhir stated, “Glymphatic failure is the common pathway of dementia, leading to the accumulation of abnormal proteins in the brain.”

Factors such as poor sleep quality, age, sedentary lifestyle, cardiovascular diseases, obesity, sleep apnoea, circadian misalignment, substance abuse, and depression can also suppress or result in the failure of the glymphatic system. Dr. Sudhir emphasized, “Good sleepers tend to live longer, weigh less, have a reduced incidence of psychiatric disorders, and maintain cognitive function for longer periods.”

In conclusion, Dr. Sudhir advised that consistently sleeping well at night can lead to better cognitive function and decrease the risk of dementia and psychiatric disorders. It is essential to prioritize quality sleep to maintain overall brain health and reduce the risk of neurodegenerative diseases.

–IANS
rvt/

Continue Reading

Trending

This will close in 5 seconds